Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
The contribution of optical coherence tomography in neurodegenerative diseases.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Myelin alters the inflammatory phenotype of macrophages by activating PPARs.
The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
Analysis of Neurogenesis during Experimental Autoimmune Encephalomyelitis Reveals Pitfalls of Bioluminescence Imaging.
Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Factors Related to Social Support in Neurological and Mental Disorders.
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor.
Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.
Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury.
Retinoic acid suppresses IL-17 production and pathogenic activity of γδ T cells in CNS autoimmunity.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis.
Age-dependent redistribution and hypersialylation of the central myelin paranodal loop membrane protein Opalin in the mouse brain.
Csf analysis and the diagnosis of neuromyelitis optica.
Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association?
Pages
« first
‹ previous
…
640
641
642
643
644
645
646
647
648
…
next ›
last »